<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref-9">
 <label>9</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Santagostino</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Martinowitz</surname>
    <given-names>U</given-names>
   </name>
   <name>
    <surname>Lissitchkov</surname>
    <given-names>T</given-names>
   </name>
   <etal/>
  </person-group>: 
  <article-title>Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial.</article-title>
  <source>
   <italic>Blood.</italic>
  </source>
  <year>2016</year>;
  <volume>127</volume>(
  <issue>14</issue>):
  <fpage>1761</fpage>â€“
  <lpage>9</lpage>. 
  <pub-id pub-id-type="doi">10.1182/blood-2015-09-669234</pub-id>
  <!--<pub-id pub-id-type="pmcid">4825413</pub-id>-->
  <?supplied-pmid 26755710?>
  <pub-id pub-id-type="pmid">26755710</pub-id>
 </mixed-citation>
 <note>
  <p>
   <ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726070117" xmlns:xlink="http://www.w3.org/1999/xlink">F1000 Recommendation</ext-link>
  </p>
 </note>
</ref>
